Sheller.com’s privacy policy is hereby updated to reflect the new European Union General Data Protection Regulations (“GDPR”). This policy describes how Sheller, P.C. collects and uses
Super Lawyers has again recognized the attorneys of Sheller P.C. in 2018. Founder Stephen A. Sheller has been selected by the organization for the fifteenth consecutive
Sheller PC’s founder, Stephen Sheller, joined other litigators, judges and state prosecutors at a conference to discuss the legal response to the opioid crisis. The
Stephen A. Sheller, who has served on the board of trustees of Drexel University since 2003 and on Drexel’s Thomas R. Kline School of Law
Sheller PC is one of five private law firms assisting the city of Philadelphia’s Law Department in its suit against pharmaceutical companies attempting to hold
In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass
A Philadelphia jury awarded Lynn Hartman $27.8 million after finding drug manufacturers Johnson & Johnson and Bayer failed to warn about the dangers of their
The National Liberty Museum honored Stephen and Sandra Sheller as “2017 Heroes of Liberty” at the 18th Annual Glass Auction & Gala held on October
Risperdal litigation in Philadelphia courts have increased significantly this year and the trend is likely to continue. Mass torts against Janssen, a Johnson & Johnson
In 1984 a federal jury in San Francisco found Dow Corning’s breast implants were “defectively designed and manufactured.” Maria Stern was awarded $1.7 M after
In ‘For Plaintiffs Bar, Taking on J&J Means Battling a Shadow Foe,’ Law.com’s Amanda Bronstad reports on the “intimate relationship” between Johnson & Johnson (J&J) and
A new type of lymphoma called breast implant-associated anapestic large-cell lymphoma has medical authorities finally agreeing that the prosthetics can cause disease. The first recognized